Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.
| less than a minute read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines

/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-07-21-10-31-24-032-6a5f4a7c1b7078c1ea9a85a1.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-08-19-14-13-52-053-6a85ba20d8729b0fe9ed3cb1.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-08-04-15-18-04-393-6a7202ac1468addd2c3b6d62.jpg)